Evidence map›Paper›PMID 40959764›Full record

ArticleFrontiers in neuroscience2025

NETSseq reveals inflammatory and aging mechanisms in distinct cell types, driving cerebellar decline in ataxia telangiectasia.

Giuliano G Stirparo, Xiao Xu, Toni Thompson, Keith Page, Jenna R M Harvey, David Cadwalladr, Jason Lawrence, Russell J Burley, Joel Juvvanapudi, Megan Roberts and 14 more

Abstract read
In one paragraph

Article in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Giuliano G StirparoCerevance Ltd, Cambridge, United Kingdom.
Xiao XuCerevance Ltd, Cambridge, United Kingdom.
Toni ThompsonCerevance Ltd, Cambridge, United Kingdom.
Keith PageCerevance Ltd, Cambridge, United Kingdom.
Jenna R M HarveyCerevance Ltd, Cambridge, United Kingdom.
David CadwalladrCerevance Ltd, Cambridge, United Kingdom.
Jason LawrenceCerevance Ltd, Cambridge, United Kingdom.
Russell J BurleyCerevance Ltd, Cambridge, United Kingdom.
Joel JuvvanapudiCerevance Ltd, Cambridge, United Kingdom.
Megan RobertsCerevance Ltd, Cambridge, United Kingdom.
Daniel F BarkerCerevance Ltd, Cambridge, United Kingdom.
Victoria MulliganCerevance Ltd, Cambridge, United Kingdom.
Chloe SherlockCerevance Ltd, Cambridge, United Kingdom.
Marina LizioCerevance Ltd, Cambridge, United Kingdom.
Louisa ChristieCerevance Ltd, Cambridge, United Kingdom.
Mani MudaliarCerevance Ltd, Cambridge, United Kingdom.
Steven SheardownCerevance Ltd, Cambridge, United Kingdom.
Brad MargusCerevance Ltd, Cambridge, United Kingdom.
Craig ThompsonCerevance Ltd, Cambridge, United Kingdom.
Louise DicksonCerevance Ltd, Cambridge, United Kingdom.
Nicola L BriceCerevance Ltd, Cambridge, United Kingdom.
Mark B CarltonCerevance Ltd, Cambridge, United Kingdom.
Justin A C PowellCerevance Ltd, Cambridge, United Kingdom.
Lee A DawsonCerevance Ltd, Cambridge, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ataxia-telangiectasia (A-T) is a rare, autosomal recessive, multisystem disorder caused by mutations in the Ataxia-Telangiectasia Mutated (ATM) gene and is characterized by a devastating and progressive neurological pathology. The cellular and molecular changes driving the neurological abnormalities associated with A-T are not well understood. Here, we applied our proprietary Nuclear Enriched Transcript Sort sequencing (NETSseq) platform to investigate changes in cell type composition and gene expression in human cerebellar post-mortem tissue from A-T and control donors. We found dysregulation in neurotransmitter signaling in granule neurons, potentially underlying the impaired motor coordination in A-T. Astrocytes and microglia have evidence of accelerated aging, with astrocytes being characterized by neurotoxic signatures, while microglia showed activation of DNA damage response pathways. Compared to single-nuclei technologies, NETSseq provided a more robust detection of genes with low abundance, a higher cell type specific expression pattern, and significantly lower levels of cross-contamination. These findings highlight the importance of NETSseq as a resource for investigating mechanisms and biological processes associated with disease, providing high-sensitivity, cell-specific insights to advance targeted therapies for neurodegenerative diseases.

Indexed as

agingastrocyteataxia telangiectasiaATR pathwayinflammationmicrogliaNETSseqneurodegeneration

Identifiers

PMID40959764
PMCPMC12434053

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.